Key result
Gross total excision plus chemoradiation achieves 12-year recurrence-free survival in a skull Ewing's sarcoma case.
Why the study?
Primary Ewing's sarcoma of the skull is a very rare malignant neoplasm, motivating a report of its clinical, neuroradiologic, and histopathologic features and therapeutic standards.
Case Report (n=1)
Radical surgical excision with safety margins combined with chemotherapy and irradiation can lead to long-term survival in patients with primary Ewing's sarcoma of the skull.
May support multimodal therapy in rare skull Ewing's sarcoma; leaves open need for larger prospective studies.
BACKGROUND AND OBJECTIVE: Primary Ewing's sarcoma of the skull is a very rare malignant neoplasm, predominantly occurring in children and adolescents. We describe here the clinical, neuroradiologic, and histopathologic features of a patient with primary Ewing's sarcoma of the skull and discuss the standards of therapy for this type of tumor. CLINICAL PRESENTATION: This 18-year-old male patient presented with a primary Ewing's sarcoma of the skull, involving the dura of the frontal and parietal lobes of the left cerebral hemisphere. He was treated with gross total surgical excision of tumor, skull reconstruction, chemotherapy, and irradiation. Twelve years after the surgery, the patient has no evidence of local recurrence or distant metastases. Radical surgical excision of the primary tumor with safety margins is thought to play a role in the favorable clinical course. CONCLUSION: The presented case is the longest surviving patient after treatment of primary Ewing's sarcoma of the skull bone. This rare type of tumor may allow better survival rates under adequate management than sarcoma elsewhere in the body.
No takes yet. Share an insight, caveat, or question.
Rainov et al. (2023) conducted a case report in Primary Ewing's sarcoma of the skull (n=1). Gross total surgical excision, skull reconstruction, chemotherapy, and irradiation was evaluated on Local recurrence or distant metastases. Gross total surgical excision combined with chemotherapy and irradiation resulted in 12-year survival without local recurrence or distant metastases in an 18-year-old male with skull Ewing's sarcoma.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: